All Web Images Videos News
Settings
Appearance
Site Icons
Font Size
Font
General
Infinite Scroll
Open Links in a New Tab
Safe Search
Galderma Delivers Record Net Sales of 3.259 B USD in the First Nine Months of 2024, Demonstrates Significant Innovation Progress, Confirms and Narrows Its Full Year Net Sales Guidance
Business Wire - Oct 23, 2024
Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024
Business Wire - Sep 16, 2024
Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends
Business Wire - Oct 24, 2024
Latham Advises L’Oréal on Acquisition of Minority Stake in Galderma
Latham & Watkins LLP - Aug 04, 2024
Galderma’s Nemluvio clinches pair of EU nods for inflammatory skin conditions
FirstWord Pharma - Feb 14, 2025
Galderma to pursue a new scientific partnership with L’Oréal to further advance its category leadership in dermatology
Business Wire - Aug 04, 2024
Galderma wins EU twin approvals for Nemluvio
The Pharma Letter - Feb 14, 2025
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
Business Wire - Dec 12, 2024
Galderma Korea shares latest breakthroughs in acne and rosacea treatment at a symposium
KBR - Feb 14, 2025
GALDERMA AND NATIONAL BREAST CANCER FOUNDATION COMMEMORATE TEN YEARS OF A BEAUTIFUL PARTNERSHIP
PR Newswire - Sep 30, 2024
More results